S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023^[*]

Zusammenfassung

Das Management von Asthma hat sich in den letzten Jahrzehnten fundamental gewandelt. Die vorliegende Leitlinie zur Diagnostik und Therapie von Asthma wurde für pneumologisch tätige Fachärztinnen und Fachärzte entwickelt, welche detaillierte und evidenzbasierte Informationen zu den neuen diagnostischen und therapeutischen Optionen von Asthma benötigen. Die Leitlinie zeigt die neue Bedeutung der Biomarker, insbesondere der Bluteosinophilen und des exhalierten NO (FeNO), in den diagnostischen Algorithmen von Asthma. Als erste Asthma-Leitlinie weltweit benennt die vorliegende Leitlinie die nachhaltige Symptomprävention und die Asthma-Remission als Asthma-Therapieziele, welche durch den Einsatz individuell angepasster, krankheitsmodifizierender Medikamente (wie inhalative Steroide, Allergenimmuntherapie oder Biologika) erreicht werden können. Die zentrale Bedeutung der Behandlung von typischen Asthma-Komorbiditäten wird zudem betont. Schließlich wird auch auf besondere Herausforderungen im Asthma-Management eingegangen, wie bspw. die Therapie von Asthma in der Schwangerschaft, die Behandlung von schwerem Asthma oder die Diagnostik und Therapie von arbeitsbedingten Asthma-Formen.

Abstract

The management of asthma has fundamentally changed during the past decades. The present guideline for the diagnosis and treatment of asthma was developed for respiratory specialists who need detailed and evidence-based information on the new diagnostic and therapeutic options in asthma. The guideline shows the new role of biomarkers, especially blood eosinophils and fractional exhaled NO (FeNO), in diagnostic algorithms of asthma. Of note, this guideline is the first worldwide to announce symptom prevention and asthma remission as the ultimate goals of asthma treatment, which can be achieved by using individually tailored, disease-modifying anti-asthmatic drugs such as inhaled steroids, allergen immunotherapy or biologics. In addition, the central role of the treatment of comorbidities is emphasized. Finally, the document addresses several challenges in asthma management, including asthma treatment during pregnancy, treatment of severe asthma or the diagnosis and treatment of work-related asthma.

• Literatur

• 1 Nationale Versorgungsleitlinie (NVL) Asthma 2020. Letzter Zugriff am 30.05.2023: https://www.leitlinien.de/themen/asthma/4-auflage
• 2 Buhl R, Bals R, Baur X. et al. Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology. Pneumologie 2017; 71: e3
• 3 Sembajwe G, Cifuentes M, Tak SW. et al. National income, self-reported wheezing and asthma diagnosis from the World Health Survey. Eur Respir J 2010; 35: 279-286
• 4 Lommatzsch M, Buhl R, Korn S. The Treatment of Mild and Moderate Asthma in Adults. Dtsch Arztebl Int 2020; 117: 434-444
• 5 Sears MR. Trends in the prevalence of asthma. Chest 2014; 145: 219-225
• 6 Asher MI, García-Marcos L, Pearce NE. et al. Trends in worldwide asthma prevalence. Eur Respir J 2020; 56: 2002094
• 7 Johnson CC, Havstad SL, Ownby DR. et al. Pediatric asthma incidence rates in the United States from 1980 to 2017. J Allergy Clin Immunol 2021; 148: 1270-1280
• 8 Safiri S, Carson-Chahhoud K, Karamzad N. et al. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019. Chest 2022; 161: 318-329
• 9 Aarab R, Vijverberg SJH, Prins M. et al. Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study. Respir Med 2019; 150: 113-119
• 10 Bisgaard H, Bønnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol 2010; 126: 187-197 quiz 198–189
• 11 Fuchs O, Bahmer T, Rabe KF. et al. Asthma transition from childhood into adulthood. Lancet Respir Med 2017; 5: 224-234
• 12 Miura S, Iwamoto H, Omori K. et al. Accelerated decline in lung function in adults with a history of remitted childhood asthma. Eur Respir J 2022; 59
• 13 Baan EJ, de Roos EW, Engelkes M. et al. Characterization of Asthma by Age of Onset: A Multi-Database Cohort Study. J Allergy Clin Immunol Pract 2022; 10: 1825-1834.e1828
• 14 Papi A, Brightling C, Pedersen SE. et al. Asthma. Lancet 2018; 391: 783-800
• 15 Kelly HW, Sternberg AL, Lescher R. et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012; 367: 904-912
• 16 Statistisches Bundesamt 2022. Letzter Zugriff am 30.05.2023: https://de.statista.com/statistik/daten/studie/1044177/umfrage/todesfaelle-aufgrund-von-asthma-in-deutschland
• 17 Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107: 937-944
• 18 Hammad H, Lambrecht BN. The basic immunology of asthma. Cell 2021; 184: 1469-1485
• 19 Lommatzsch M. Immune Modulation in Asthma: Current Concepts and Future Strategies. Respiration 2020; 99: 566-576
• 20 Holgate ST, Wenzel S, Postma DS. et al. Asthma. Nat Rev Dis Primers 2015; 1: 15025
• 21 El-Husseini ZW, Gosens R, Dekker F. et al. The genetics of asthma and the promise of genomics-guided drug target discovery. Lancet Respir Med 2020; 8: 1045-1056
• 22 Reyes-Angel J, Kaviany P, Rastogi D. et al. Obesity-related asthma in children and adolescents. Lancet Child Adolesc Health 2022; 6: 713-724
• 23 Thyagarajan B, Jacobs Jr DR, Apostol GG. et al. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res 2008; 9: 31
• 24 Haldar P, Pavord ID, Shaw DE. et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224
• 25 Torchio R, Gobbi A, Gulotta C. et al. Mechanical effects of obesity on airway responsiveness in otherwise healthy humans. J Appl Physiol (1985) 2009; 107: 408-416
• 26 Sears MR, Greene JM, Willan AR. et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422
• 27 Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18: 726-735
• 28 Platts-Mills T, Vaughan J, Squillace S. et al. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001; 357: 752-756
• 29 Lau S, Illi S, Platts-Mills TA. et al. Longitudinal study on the relationship between cat allergen and endotoxin exposure, sensitization, cat-specific IgG and development of asthma in childhood – report of the German Multicentre Allergy Study (MAS 90). Allergy 2005; 60: 766-773
• 30 Illi S, von Mutius E, Lau S. et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368: 763-770
• 31 Deifl S, Bohle B. Factors influencing the allergenicity and adjuvanticity of allergens. Immunotherapy 2011; 3: 881-893
• 32 Schaub B, Lauener R, von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2006; 117: 969-977 quiz 978
• 33 Brunwasser SM, Snyder BM, Driscoll AJ. et al. Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis. Lancet Respir Med 2020; 8: 795-806
• 34 Pavord ID, Beasley R, Agusti A. et al. After asthma: redefining airways diseases. Lancet 2018; 391: 350-400
• 35 Jackson DJ, Evans MD, Gangnon RE. et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012; 185: 281-285
• 36 Thurston GD, Balmes JR, Garcia E. et al. Outdoor Air Pollution and New-Onset Airway Disease. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 2020; 17: 387-398
• 37 von Mutius E, Smits HH. Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention. Lancet 2020; 396: 854-866
• 38 Litonjua AA, Carey VJ, Laranjo N. et al. Six-Year Follow-up of a Trial of Antenatal Vitamin D for Asthma Reduction. N Engl J Med 2020; 382: 525-533
• 39 Castro M, King TS, Kunselman SJ. et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. Jama 2014; 311: 2083-2091
• 40 Jolliffe DA, Greenberg L, Hooper RL. et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med 2017; 5: 881-890
• 41 Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013; 41: 716-726
• 42 Sunde RB, Thorsen J, Pedersen CT. et al. Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood. Eur Respir J 2022; 59
• 43 Bal C, Idzko M, Škrgat S. et al. Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort. Eur Respir J 2022; 59
• 44 Lommatzsch M, Klein M, Stoll P. et al. Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma. Allergy 2021; 76: 3199-3202
• 45 Klein DK, Silberbrandt A, Frøssing L. et al. Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma. Eur Respir J 2022; 60
• 46 Kopp MV, Muche-Borowski C, Abou-Dakn M. et al. S3 guideline Allergy Prevention. Allergol Select 2022; 6: 61-97
• 47 Burrows B, Martinez FD, Halonen M. et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320: 271-277
• 48 Tomassen P, Jarvis D, Newson R. et al. Staphylococcus aureus enterotoxin-specific IgE is associated with asthma in the general population: a GA(2)LEN study. Allergy 2013; 68: 1289-1297
• 49 Bousquet J, Anto JM, Bachert C. et al. Allergic rhinitis. Nat Rev Dis Primers 2020; 6: 95
• 50 Chipps BE, Haselkorn T, Paknis B. et al. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II. J Allergy Clin Immunol 2018; 141: 1590-1597.e1599
• 51 Lommatzsch M, Korn S, Buhl R. et al. Against all odds: anti-IgE for intrinsic asthma?. Thorax 2014; 69: 94-96
• 52 Arbes SJ. Do all asthmatics with atopy have atopic asthma?. J Allergy Clin Immunol 2012; 130: 1202-1204
• 53 Pfaar O, Ankermann T, Augustin M. et al. Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD). Allergol Select 2022; 6: 167-232
• 54 Brusselle GG, Koppelman GH. Biologic Therapies for Severe Asthma. N Engl J Med 2022; 386: 157-171
• 55 Lommatzsch M, Klein M, Stoll P. et al. Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma. Thorax 2019; 74: 417-418
• 56 Global Initiative for Asthma (GINA) 2022. Letzter Zugriff am 25.05.2023: www.ginasthma.com
• 57 Jackson DJ, Busby J, Pfeffer PE. et al. Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era. Thorax 2021; 76: 220-227
• 58 Chipps BE, Jarjour N, Calhoun WJ. et al. A Comprehensive Analysis of the Stability of Blood Eosinophil Levels. Ann Am Thorac Soc 2021; 18: 1978-1987
• 59 Nair P, Surette MG, Virchow JC. Neutrophilic asthma: misconception or misnomer?. Lancet Respir Med 2021; 9: 441-443
• 60 McGrath KW, Icitovic N, Boushey HA. et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012; 185: 612-619
• 61 Heaney LG, Perez de Llano L, Al-Ahmad M. et al. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort. Chest 2021; 160: 814-830
• 62 Fleming L, Tsartsali L, Wilson N. et al. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax 2012; 67: 675-681
• 63 Hartl S, Breyer MK, Burghuber OC. et al. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J 2020; 55
• 64 Price DB, Rigazio A, Campbell JD. et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med 2015; 3: 849-858
• 65 Brusselle GG, Maes T, Bracke KR. Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma. Nat Med 2013; 19: 977-979
• 66 Berry M, Morgan A, Shaw DE. et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62: 1043-1049
• 67 Côté A, Russell RJ, Boulet LP. et al. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report. Chest 2020; 158: 68-96
• 68 Kardos P, Dinh QT, Fuchs KH. et al. German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough. Respir Med 2020; 170: 105939
• 69 Holmes J, McGarvey LP, Birring SS. et al. An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma. Eur Respir J 2022;
• 70 Hopkins C. Chronic Rhinosinusitis with Nasal Polyps. N Engl J Med 2019; 381: 55-63
• 71 White AA, Stevenson DD. Aspirin-Exacerbated Respiratory Disease. N Engl J Med 2018; 379: 1060-1070
• 72 Rajan JP, Wineinger NE, Stevenson DD. et al. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. J Allergy Clin Immunol 2015; 135: 676-681.e671
• 73 Bachert C, Han JK, Desrosiers M. et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 2019; 394: 1638-1650
• 74 Xu X, Reitsma S, Wang Y. et al. Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID-exacerbated respiratory disease. Allergy 2022; 77: 3593-3605
• 75 Quint T, Dahm V, Ramazanova D. et al. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization. J Allergy Clin Immunol Pract 2022; 10: 506-516.e506
• 76 Schneider S, Poglitsch K, Morgenstern C. et al. Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease (N-ERD). Eur Respir J 2022;
• 77 Taniguchi M, Heffler E, Olze H. et al. The Role of Omalizumab in NSAID-Exacerbated Respiratory Disease: A Narrative Review. J Allergy Clin Immunol Pract 2022; 10: 2570-2578
• 78 Randolph C. An update on exercise-induced bronchoconstriction with and without asthma. Curr Allergy Asthma Rep 2009; 9: 433-438
• 79 Carlsen KH. The breathless adolescent asthmatic athlete. Eur Respir J 2011; 38: 713-720
• 80 Lamprecht B, McBurnie MA, Vollmer WM. et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011; 139: 752-763
• 81 Criée CP, Baur X, Berdel D. et al. Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine. Pneumologie 2015; 69: 147-164
• 82 Reed CE. Asthma in the elderly: diagnosis and management. J Allergy Clin Immunol 2010; 126: 681-687 quiz 688–689
• 83 Lommatzsch M, Lindner Y, Edner A. et al. Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax 2009; 64: 763-769
• 84 Fairs A, Agbetile J, Hargadon B. et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182: 1362-1368
• 85 Rodrigues J, Caruthers C, Azmeh R. et al. The spectrum of allergic fungal diseases of the upper and lower airways. Expert Rev Clin Immunol 2016; 12: 531-550
• 86 Lommatzsch M, Virchow JC. Severe asthma: definition, diagnosis and treatment. Dtsch Arztebl Int 2014; 111: 847-855
• 87 Hekking PW, Wener RR, Amelink M. et al. The prevalence of severe refractory asthma. J Allergy Clin Immunol 2015; 135: 896-902
• 88 Chung KF, Wenzel SE, Brozek JL. et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343-373
• 89 Beasley R, Harper J, Bird G. et al. Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med 2019; 199: 1471-1477
• 90 Maijers I, Kearns N, Harper J. et al. Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma. Eur Respir J 2020; 55
• 91 Milger K, Skowasch D, Hamelmann E. et al. Bronchodilator reversibility in the GAN severe asthma cohort. J Investig Allergol Clin Immunol 2023; (in press).
• 92 Kole TM, Vanden Berghe E, Kraft M. et al. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study. Lancet Respir Med 2023; 11: 55-64
• 93 Götz M, Eber E, Frischer T. et al. Recurring obstructive bronchitis and asthmatic bronchitis in preschool aged children. Wien Klin Wochenschr 2006; 118: 302-306
• 94 Brand PL, Baraldi E, Bisgaard H. et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096-1110
• 95 Gappa M. Asthma bronchiale im Kleinkind- und Vorschulalter. Der Pneumologe 2018; 15: 123-129
• 96 Martinez FD, Wright AL, Taussig LM. et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133-138
• 97 Brand PL, Caudri D, Eber E. et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 2014; 43: 1172-1177
• 98 Criée CP, Sorichter S, Smith HJ. et al. Body plethysmography – its principles and clinical use. Respir Med 2011; 105: 959-971
• 99 Stanojevic S, Kaminsky DA, Miller MR. et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022; 60
• 100 Brzozowska A, Majak P, Grzelewski T. et al. Measurement of specific airway resistance decreased the risk of delay in asthma diagnosis in children. Allergy Asthma Proc 2009; 30: 47-54
• 101 Quanjer PH, Stanojevic S, Cole TJ. et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343
• 102 Jenkins C, Seccombe L, Tomlins R. Investigating asthma symptoms in primary care. Bmj 2012; 344: e2734
• 103 Gaillard EA, Kuehni CE, Turner S. et al. European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years. Eur Respir J 2021; 58
• 104 Louis R, Satia I, Ojanguren I. et al. European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults. Eur Respir J 2022; 60: 2101585
• 105 Lommatzsch M. Airway hyperresponsiveness: new insights into the pathogenesis. Semin Respir Crit Care Med 2012; 33: 579-587
• 106 Cockcroft DW, Davis BE, Blais CM. Direct bronchoprovocation test methods: history 1945-2018. Expert Rev Respir Med 2019; 13: 279-289
• 107 Schneider A, Schwarzbach J, Faderl B. et al. Whole-Body Plethysmography in Suspected Asthma: A Prospective Study of Its Added Diagnostic Value in 302 Patients. Dtsch Arztebl Int 2015; 112: 405-411
• 108 Moeller A, Carlsen KH, Sly PD. et al. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation. Eur Respir Rev 2015; 24: 204-215
• 109 Lex C, Zacharasiewicz A, Schulze J. et al. Bronchiale Provokation im Kindes- und Jugendalter. Monatsschrift Kinderheilkunde 2015; 163: 826-832
• 110 Hughes JM, Pride NB. Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components. Am J Respir Crit Care Med 2012; 186: 132-139
• 111 Neder JA, Berton DC, O'Donnell DE. The Lung Function Laboratory to Assist Clinical Decision-making in Pulmonology: Evolving Challenges to an Old Issue. Chest 2020; 158: 1629-1643
• 112 Petsky HL, Cates CJ, Lasserson TJ. et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012; 67: 199-208
• 113 Zacharasiewicz A, Wilson N, Lex C. et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171: 1077-1082
• 114 Dweik RA, Boggs PB, Erzurum SC. et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615
• 115 Rupani H, Kent BD. Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management. Chest 2022; 161: 906-917
• 116 Loewenthal L, Menzies-Gow A. FeNO in Asthma. Semin Respir Crit Care Med 2022; 43: 635-645
• 117 Khatri SB, Iaccarino JM, Barochia A. et al. Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2021; 204: e97-e109
• 118 Pedrosa M, Cancelliere N, Barranco P. et al. Usefulness of exhaled nitric oxide for diagnosing asthma. J Asthma 2010; 47: 817-821
• 119 Karrasch S, Linde K, Rücker G. et al. Accuracy of FENO for diagnosing asthma: a systematic review. Thorax 2017; 72: 109-116
• 120 Kraft M, Brusselle G, FitzGerald JM. et al. Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma. Eur Respir J 2021; 58
• 121 Couillard S, Laugerud A, Jabeen M. et al. Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide. Thorax 2022; 77: 199-202
• 122 Pijnenburg MW, Hofhuis W, Hop WC. et al. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60: 215-218
• 123 Turner S, Cotton S, Wood J. et al. Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial. Lancet Respir Med 2022; 10: 584-592
• 124 Butler CA, Heaney LG. Fractional exhaled nitric oxide and asthma treatment adherence. Curr Opin Allergy Clin Immunol 2021; 21: 59-64
• 125 Couillard S, Shrimanker R, Lemaire-Paquette S. et al. Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing. Thorax 2022; 77: 933-938
• 126 Powell H, Murphy VE, Taylor DR. et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011; 378: 983-990
• 127 Lommatzsch M, Stoll P, Winkler J. et al. Eosinophilic pleural effusion and stroke with cutaneous vasculitis: Two cases of dupilumab-induced hypereosinophilia. Allergy 2021; 76: 2920-2923
• 128 FitzGerald JM, Bleecker ER, Menzies-Gow A. et al. Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. Lancet Respir Med 2018; 6: 51-64
• 129 Castro M, Corren J, Pavord ID. et al. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. N Engl J Med 2018; 378: 2486-2496
• 130 Menzies-Gow A, Corren J, Bourdin A. et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med 2021; 384: 1800-1809
• 131 Hanania NA, Wenzel S, Rosén K. et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med 2013; 187: 804-811
• 132 Ewig S, Höffken G, Kern WV. et al. Management of Adult Community-acquired Pneumonia and Prevention – Update 2016. Pneumologie 2016; 70: 151-200
• 133 Graif Y, Yigla M, Tov N. et al. Value of a negative aeroallergen skin-prick test result in the diagnosis of asthma in young adults: correlative study with methacholine challenge testing. Chest 2002; 122: 821-825
• 134 Chan EY, Dundas I, Bridge PD. et al. Skin-prick testing as a diagnostic aid for childhood asthma. Pediatr Pulmonol 2005; 39: 558-562
• 135 Kleine-Tebbe J, Jappe U. Molecular allergy diagnostic tests: development and relevance in clinical practice. Allergol Select 2017; 1: 169-189
• 136 Hemmer W, Altmann F, Holzweber F. et al. ImmunoCAP cellulose displays cross-reactive carbohydrate determinant (CCD) epitopes and can cause false-positive test results in patients with high anti-CCD IgE antibody levels. J Allergy Clin Immunol 2018; 141: 372-381.e373
• 137 Holzweber F, Svehla E, Fellner W. et al. Inhibition of IgE binding to cross-reactive carbohydrate determinants enhances diagnostic selectivity. Allergy 2013; 68: 1269-1277
• 138 Mehl A, Niggemann B, Keil T. et al. Skin prick test and specific serum IgE in the diagnostic evaluation of suspected cowʼs milk and hen’s egg allergy in children: does one replace the other?. Clin Exp Allergy 2012; 42: 1266-1272
• 139 Gauvreau GM, Davis BE, Scadding G. et al. Allergen provocation tests in respiratory research: building on 50 years of experience. Eur Respir J 2022; 60
• 140 Heffler E, Pizzimenti S, Guida G. et al. Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. J Asthma 2015; 52: 931-934
• 141 LindenSmith J, Morrison D, Deveau C. et al. Overdiagnosis of asthma in the community. Can Respir J 2004; 11: 111-116
• 142 de Jong CCM, Pedersen ESL, Mozun R. et al. Diagnosis of asthma in children: the contribution of a detailed history and test results. Eur Respir J 2019; 54
• 143 Chang AB, Oppenheimer JJ, Irwin RS. Managing Chronic Cough as a Symptom in Children and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest 2020; 158: 303-329
• 144 Pedersen ESL, Ardura-Garcia C, de Jong CCM. et al. Diagnosis in children with exercise-induced respiratory symptoms: A multi-center study. Pediatr Pulmonol 2021; 56: 217-225
• 145 Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010; 376: 803-813
• 146 Skloot GS, Busse PJ, Braman SS. et al. An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly. Ann Am Thorac Soc 2016; 13: 2064-2077
• 147 Rackemann FM. Intrinsic Asthma. Bull N Y Acad Med 1947; 23: 302-306
• 148 Singh D, Agusti A, Anzueto A. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J 2019; 53: 1900164
• 149 Goussard P, Pohunek P, Eber E. et al. Pediatric bronchoscopy: recent advances and clinical challenges. Expert Rev Respir Med 2021; 15: 453-475
• 150 Eber E, Antón-Pacheco JL, de Blic J. et al. ERS statement: interventional bronchoscopy in children. Eur Respir J 2017; 50: 1700901
• 151 Bush A. This Child’s Asthma Appears to Be Severe: But Where Actually Is the Severe Problem?. Acta Med Acad 2020; 49: 103-116
• 152 Teague WG, Lawrence MG, Shirley DT. et al. Lung Lavage Granulocyte Patterns and Clinical Phenotypes in Children with Severe, Therapy-Resistant Asthma. J Allergy Clin Immunol Pract 2019; 7: 1803-1812.e1810
• 153 Fernandez-Trujillo L, López-Castilla V, Morales EI. et al. Unsuspected foreign-body aspiration in adult patient with status asthmaticus: Case report. Ann Med Surg (Lond) 2020; 56: 1-4
• 154 Nuutinen J. Acquired tracheobronchomalacia. Eur J Respir Dis 1982; 63: 380-387
• 155 Lang DM, Simon RA, Mathison DA. et al. Safety and possible efficacy of fiberoptic bronchoscopy with lavage in the management of refractory asthma with mucous impaction. Ann Allergy 1991; 67: 324-330
• 156 Millman M, Goodman AH, Goldstein IM. et al. Status Asthmaticus: use of acetylcysteine during bronchoscopy and lavage to remove mucous plugs. Ann Allergy 1983; 50: 85-93
• 157 Abia-Trujillo D, Majid A, Johnson MM. et al. Central Airway Collapse, an Underappreciated Cause of Respiratory Morbidity. Mayo Clin Proc 2020; 95: 2747-2754
• 158 Kheir F, Majid A. Tracheobronchomalacia and Excessive Dynamic Airway Collapse: Medical and Surgical Treatment. Semin Respir Crit Care Med 2018; 39: 667-673
• 159 Wahn U, Bachert C, Heinrich J. et al. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy 2019; 74: 594-604
• 160 Zielen S, Devillier P, Heinrich J. et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis. Allergy 2018; 73: 165-177
• 161 Valovirta E, Petersen TH, Piotrowska T. et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol 2018; 141: 529-538.e513
• 162 Lommatzsch M, Brusselle GG, Canonica GW. et al. Disease-modifying anti-asthmatic drugs. Lancet 2022; 399: 1664-1668
• 163 Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010; Cd001186
• 164 Calderon MA, Casale TB, Nelson HS. et al. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol 2013; 132: 1322-1336
• 165 Virchow JC, Backer V, Kuna P. et al. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial. JAMA 2016; 315: 1715-1725
• 166 Mosbech H, Deckelmann R, de Blay F. et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2014; 134: 568-575.e567
• 167 Fritzsching B, Contoli M, Porsbjerg C. et al. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study. Lancet Reg Health Eur 2022; 13: 100275
• 168 Woehlk C, Von Bülow A, Ghanizada M. et al. Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study. Eur Respir J 2022; 60: 2200446
• 169 Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev 2014; 2014: Cd009471
• 170 Powell H, Gibson PG. Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review. Thorax 2004; 59: 1041-1045
• 171 Administration USFD. Black Box Warning (Montelukast). https://wwwfdagov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug2020
• 172 Chrystyn H, van der Palen J, Sharma R. et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med 2017; 27: 22
• 173 Wollsching-Strobel M, Butt U, Majorski DS. et al. Evolution of Web-Based Training Videos Provided by the German Respiratory League for the Correct Inhalation Technique. Respiration 2022; 101: 757-765
• 174 Müller T, Müller A, Hübel C. et al. Optimizing inhalation technique using web-based videos in obstructive lung diseases. Respir Med 2017; 129: 140-144
• 175 Dekhuijzen PNR, Levy ML, Corrigan CJ. et al. Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist. J Allergy Clin Immunol Pract 2022; 10: 1813-1824.e1811
• 176 Usmani OS, Lavorini F, Marshall J. et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res 2018; 19: 10
• 177 Laube BL, Janssens HM, de Jongh FH. et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37: 1308-1331
• 178 Usmani OS, Hickey AJ, Guranlioglu D. et al. The Impact of Inhaler Device Regimen in Patients with Asthma or COPD. J Allergy Clin Immunol Pract 2021; 9: 3033-3040.e3031
• 179 Bosnic-Anticevich SZ, Sinha H, So S. et al. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma 2010; 47: 251-256
• 180 van der Meer V, van Stel HF, Bakker MJ. et al. Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respir Res 2010; 11: 74
• 181 Thomas M, Price D, Chrystyn H. et al. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med 2009; 9: 1
• 182 Bjermer L. The importance of continuity in inhaler device choice for asthma and chronic obstructive pulmonary disease. Respiration 2014; 88: 346-352
• 183 Leach CL, Colice GL. A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times. J Aerosol Med Pulm Drug Deliv 2010; 23: 355-361
• 184 Nair A, Menzies D, Hopkinson P. et al. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler. Br J Clin Pharmacol 2009; 67: 191-198
• 185 Small M, Anderson P, Vickers A. et al. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Ther 2011; 28: 202-212
• 186 Williams LK, Peterson EL, Wells K. et al. A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. J Allergy Clin Immunol 2010; 126: 225-231 231.e221–224
• 187 Mehuys E, Van Bortel L, De Bolle L. et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 2008; 31: 790-799
• 188 Jia X, Zhou S, Luo D. et al. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis. J Clin Pharm Ther 2020; 45: 904-917
• 189 Rodrigues AT, Romano S, Romão M. et al. Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial. Respir Med 2021; 185: 106507
• 190 Martin AR, Finlay WH. Nebulizers for drug delivery to the lungs. Expert Opin Drug Deliv 2015; 12: 889-900
• 191 Normansell R, Kew KM, Stovold E. Interventions to improve adherence to inhaled steroids for asthma. Cochrane Database Syst Rev 2017; 4: Cd012226
• 192 Gregoriano C, Dieterle T, Breitenstein AL. et al. Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial. Respir Res 2019; 20: 273
• 193 Foster JM, Reddel HK, Usherwood T. et al. Patient-perceived acceptability and behaviour change benefits of inhaler reminders and adherence feedback: A qualitative study. Respir Med 2017; 129: 39-45
• 194 Jeminiwa R, Hohmann L, Qian J. et al. Impact of eHealth on medication adherence among patients with asthma: A systematic review and meta-analysis. Respir Med 2019; 149: 59-68
• 195 Moore A, Preece A, Sharma R. et al. A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients. Eur Respir J 2021; 57: 2003103
• 196 Press VG, Arora VM, Trela KC. et al. Effectiveness of Interventions to Teach Metered-Dose and Diskus Inhaler Techniques. A Randomized Trial. Ann Am Thorac Soc 2016; 13: 816-824
• 197 Hess DR. The mask for noninvasive ventilation: principles of design and effects on aerosol delivery. J Aerosol Med 2007; 20 (Suppl. 01) S85-98 discussion S98–89
• 198 Dhand R. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliv 2008; 21: 45-60
• 199 Ditcham W, Murdzoska J, Zhang G. et al. Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma. J Aerosol Med Pulm Drug Deliv 2014; 27 (Suppl. 01) S63-75
• 200 Parsons JP, Hallstrand TS, Mastronarde JG. et al. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2013; 187: 1016-1027
• 201 Papi A, Canonica GW, Maestrelli P. et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med 2007; 356: 2040-2052
• 202 Beasley R, Holliday M, Reddel HK. et al. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. N Engl J Med 2019; 380: 2020-2030
• 203 Crossingham I, Turner S, Ramakrishnan S. et al. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review. BMJ Evid Based Med 2022; 27: 178-184
• 204 Weiler JM, Brannan JD, Randolph CC. et al. Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol 2016; 138: 1292-1295.e1236
• 205 Nwaru BI, Ekström M, Hasvold P. et al. Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J 2020; 55: 1901872
• 206 Bateman ED, Reddel HK, O'Byrne PM. et al. As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma. N Engl J Med 2018; 378: 1877-1887
• 207 O'Byrne PM, FitzGerald JM, Bateman ED. et al. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. N Engl J Med 2018; 378: 1865-1876
• 208 Hardy J, Baggott C, Fingleton J. et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet 2019; 394: 919-928
• 209 Reddel HK, FitzGerald JM, Bateman ED. et al. GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J 2019; 53: 1901046
• 210 Reddel HK, Busse WW, Pedersen S. et al. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. Lancet 2017; 389: 157-166
• 211 Weinberger M, Hendeles L. Theophylline in asthma. N Engl J Med 1996; 334: 1380-1388
• 212 Welsh EJ, Cates CJ. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma. Cochrane Database Syst Rev 2010; 2010: Cd008418
• 213 Beasley R, Bruce P, Houghton C. et al. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review. J Allergy Clin Immunol Pract 2023; 11: 762-772.e1
• 214 Clarridge K, Chin S, Eworuke E. et al. A Boxed Warning for Montelukast: The FDA Perspective. J Allergy Clin Immunol Pract 2021; 9: 2638-2641
• 215 Ni Chroinin M, Greenstone I, Lasserson TJ. et al. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database Syst Rev 2009; Cd005307
• 216 Sobieraj DM, Weeda ER, Nguyen E. et al. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. JAMA 2018; 319: 1485-1496
• 217 Buhl R, Tanase AM, Hosoe M. et al. A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler or Twisthaler in patients with asthma. Pulm Pharmacol Ther 2020; 62: 101919
• 218 Kornmann O, Mucsi J, Kolosa N. et al. Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings. Respir Med 2020; 161: 105809
• 219 van Zyl-Smit RN, Krüll M, Gessner C. et al. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study. Lancet Respir Med 2020; 8: 987-999
• 220 Kew KM, Karner C, Mindus SM. et al. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 2013; 2013: Cd009019
• 221 Papi A, Corradi M, Pigeon-Francisco C. et al. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med 2013; 1: 23-31
• 222 Patel M, Pilcher J, Pritchard A. et al. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med 2013; 1: 32-42
• 223 Ducharme FM, Ni Chroinin M, Greenstone I. et al. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev 2010; Cd005533
• 224 Pauwels RA, Löfdahl CG, Postma DS. et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405-1411
• 225 Crompton GK, Ayres JG, Basran G. et al. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Am J Respir Crit Care Med 1999; 159: 824-828
• 226 Wallaert B, Brun P, Ostinelli J. et al. A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group. Respir Med 1999; 93: 33-38
• 227 Bateman ED, Harrison TW, Quirce S. et al. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011; 12: 38
• 228 O'Byrne PM, Naya IP, Kallen A. et al. Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control. Chest 2008; 134: 1192-1199
• 229 Lee LA, Bailes Z, Barnes N. et al. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet Respir Med 2021; 9: 69-84
• 230 Kerstjens HA, Disse B, Schröder-Babo W. et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011; 128: 308-314
• 231 Kerstjens HA, Engel M, Dahl R. et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012; 367: 1198-1207
• 232 Peters SP, Kunselman SJ, Icitovic N. et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363: 1715-1726
• 233 Gessner C, Kornmann O, Maspero J. et al. Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON). Respir Med 2020; 170: 106021
• 234 Watz H, Hohlfeld JM, Singh D. et al. Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study. Respir Res 2020; 21: 87
• 235 Kerstjens HAM, Maspero J, Chapman KR. et al. Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study. Lancet Respir Med 2020; 8: 1000-1012
• 236 Virchow JC, Kuna P, Paggiaro P. et al. Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials. Lancet 2019; 394: 1737-1749
• 237 Malo JL, Cartier A, Ghezzo H. et al. Comparison of four-times-a-day and twice-a-day dosing regimens in subjects requiring 1200 micrograms or less of budesonide to control mild to moderate asthma. Respir Med 1995; 89: 537-543
• 238 Vogelmeier C, Kardos P, Hofmann T. et al. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. Eur Respir J 2015; 45: 1273-1282
• 239 Hill JM. Nebulised corticosteroids in the treatment of patients with asthma. Thorax 1999; 54: 661-663
• 240 Blakey J, Chung LP, McDonald VM. et al. Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand. Respirology 2021; 26: 1112-1130
• 241 Skov IR, Madsen H, Henriksen DP. et al. Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality. Eur Respir J 2022; 60: 2103054
• 242 Heatley H, Tran TN, Bourdin A. et al. Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax 2022;
• 243 Mash B, Bheekie A, Jones PW. Inhaled vs oral steroids for adults with chronic asthma. Cochrane Database Syst Rev 2001; Cd002160
• 244 Thomasius F, Baum E, Bernecker P. et al. DVO Leitlinie 2017 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und Männern. Kurzversion 2018; 27: 154-160
• 245 Davies H, Olson L, Gibson P. Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev 2000; 1998: Cd000391
• 246 Martinez FD, Chinchilli VM, Morgan WJ. et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377: 650-657
• 247 Papi A, Chipps BE, Beasley R. et al. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. N Engl J Med 2022; 386: 2071-2083
• 248 Buhl R, Bel E, Bourdin A. et al. Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion. J Allergy Clin Immunol Pract 2022; 10: 422-432
• 249 Normansell R, Walker S, Milan SJ. et al. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev 2014; Cd003559
• 250 Garcia G, Magnan A, Chiron R. et al. A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma. Chest 2013; 144: 411-419
• 251 Voskamp AL, Gillman A, Symons K. et al. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract 2015; 3: 192-199
• 252 Li JX, Fan LC, Li MH. et al. Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature. Respir Med 2017; 122: 33-42
• 253 Jin M, Douglass JA, Elborn JS. et al. Omalizumab in allergic bronchopulmonary aspergillosis (ABPA): A systematic review and meta-analysis. J Allergy Clin Immunol Pract 2022; 11: 896-905
• 254 Holguin F, Cardet JC, Chung KF. et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 2020; 55: 1900588
• 255 Humbert M, Taillé C, Mala L. et al. Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study. Eur Respir J 2018; 51: 1702523
• 256 Farne HA, Wilson A, Milan S. et al. Anti-IL-5 therapies for asthma. Cochrane Database Syst Rev 2022; 7: Cd010834
• 257 Wechsler ME, Akuthota P, Jayne D. et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med 2017; 376: 1921-1932
• 258 Han JK, Bachert C, Fokkens W. et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 2021; 9: 1141-1153
• 259 Agache I, Song Y, Rocha C. et al. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma. Allergy 2020; 75: 1058-1068
• 260 Bacharier LB, Maspero JF, Katelaris CH. et al. Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma. N Engl J Med 2021; 385: 2230-2240
• 261 Rabe KF, Nair P, Brusselle G. et al. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma. N Engl J Med 2018; 378: 2475-2485
• 262 Blauvelt A, de Bruin-Weller M, Gooderham M. et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet 2017; 389: 2287-2303
• 263 Dellon ES, Rothenberg ME, Collins MH. et al. Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. N Engl J Med 2022; 387: 2317-2330
• 264 Parnes JR, Molfino NA, Colice G. et al. Targeting TSLP in Asthma. J Asthma Allergy 2022; 15: 749-765
• 265 Roan F, Obata-Ninomiya K, Ziegler SF. Epithelial cell-derived cytokines: more than just signaling the alarm. J Clin Invest 2019; 129: 1441-1451
• 266 Gauvreau GM, Sehmi R, Ambrose CS. et al. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opin Ther Targets 2020; 24: 777-792
• 267 Porsbjerg CM, Sverrild A, Lloyd CM. et al. Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics. Eur Respir J 2020; 56: 2000260
• 268 Diver S, Khalfaoui L, Emson C. et al. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med 2021; 9: 1299-1312
• 269 Wechsler ME, Menzies-Gow A, Brightling CE. et al. Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study. Lancet Respir Med 2022; 10: 650-660
• 270 Chapman KR, Albers FC, Chipps B. et al. The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma. Allergy 2019; 74: 1716-1726
• 271 Abbas F, Georas S, Cai X. et al. Asthma biologics: Real-world effectiveness, impact of switching biologics, and predictors of response. Ann Allergy Asthma Immunol 2021; 127: 655-660.e651
• 272 Mümmler C, Munker D, Barnikel M. et al. Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy. J Allergy Clin Immunol Pract 2021; 9: 1177-1185.e1174
• 273 Lommatzsch M, Suhling H, Korn S. et al. Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations. Allergy 2022; 77: 2839-2843
• 274 Brennan V, Martin-Grace J, Greene G. et al. The Contribution of Oral and Inhaled Glucocorticoids to Adrenal Insufficiency in Asthma. J Allergy Clin Immunol Pract 2022; 10: 2614-2623
• 275 Menzies-Gow A, Gurnell M, Heaney LG. et al. Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. Lancet Respir Med 2022; 10: 47-58
• 276 Bornstein SR, Allolio B, Arlt W. et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 364-389
• 277 Wechsler ME, Laviolette M, Rubin AS. et al. Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 2013; 132: 1295-1302
• 278 Pretolani M, Dombret MC, Thabut G. et al. Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma. Am J Respir Crit Care Med 2014; 190: 1452-1454
• 279 Castro M, Rubin AS, Laviolette M. et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010; 181: 116-124
• 280 Chupp G, Kline JN, Khatri SB. et al. Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study. Chest 2022; 161: 614-628
• 281 Chaudhuri R, Rubin A, Sumino K. et al. Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials. Lancet Respir Med 2021; 9: 457-466
• 282 Vogelberg C, Moroni-Zentgraf P, Leonaviciute-Klimantaviciene M. et al. A randomised dose-ranging study of tiotropium Respimat in children with symptomatic asthma despite inhaled corticosteroids. Respir Res 2015; 16: 20
• 283 Hamelmann E, Bateman ED, Vogelberg C. et al. Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial. J Allergy Clin Immunol 2016; 138: 441-450.e448
• 284 Hamelmann E, Bernstein JA, Vandewalker M. et al. A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma. Eur Respir J 2017; 49: 1601100
• 285 Szefler SJ, Murphy K, Harper 3rd T. et al. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma. J Allergy Clin Immunol 2017; 140: 1277-1287
• 286 Vogelberg C, Engel M, Laki I. et al. Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma. J Allergy Clin Immunol Pract 2018; 6: 2160-2162.e2169
• 287 Liu L, Zhou P, Wang Z. et al. Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis. Front Pediatr 2022; 10: 851177
• 288 Jackson DJ, Bacharier LB, Gergen PJ. et al. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet 2022; 400: 502-511
• 289 Wetzke M, Funken D, Ahrens FO. et al. Mepolizumab Treatment in Severe Pediatric Asthma: First Multicentric Real-World Data. Klin Padiatr 2022; 234: 305-308
• 290 Bush A. How to Choose the Correct Drug in Severe Pediatric Asthma. Front Pediatr 2022; 10: 902168
• 291 Yao TC, Wang JY, Chang SM. et al. Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children. JAMA Pediatr 2021; 175: 723-729
• 292 Gibson PG, Powell H, Coughlan J. et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003; Cd001117
• 293 Gibson PG, Powell H, Coughlan J. et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 2002; Cd001005
• 294 Schacher C, Dhein Y, Münks-Lederer C. et al. [Evaluation of a structured outpatient education program for adult asthmatics]. Dtsch Med Wochenschr 2006; 131: 606-610
• 295 Wang L, Timmer S, Rosenman K. Assessment of a University-Based Outpatient Asthma Education Program for Children. J Pediatr Health Care 2020; 34: 128-135
• 296 Petro W, Wettengel R, Worth H. [Recommendations for structured patient training in obstructive respiratory tract diseases. Patient Education Study group of the German Society of Pneumology and the German Respiratory Tract League of the German Society of Pneumology]. Med Klin (Munich) 1995; 90: 515-519
• 297 Powell H, Gibson PG. Options for self-management education for adults with asthma. Cochrane Database Syst Rev 2003; 2002: Cd004107
• 298 Pinnock H, Epiphaniou E, Pearce G. et al. Implementing supported self-management for asthma: a systematic review and suggested hierarchy of evidence of implementation studies. BMC Med 2015; 13: 127
• 299 Denford S, Taylor RS, Campbell JL. et al. Effective behavior change techniques in asthma self-care interventions: systematic review and meta-regression. Health Psychol 2014; 33: 577-587
• 300 Kirk S, Beatty S, Callery P. et al. The effectiveness of self-care support interventions for children and young people with long-term conditions: a systematic review. Child Care Health Dev 2013; 39: 305-324
• 301 Marcano Belisario JS, Huckvale K, Greenfield G. et al. Smartphone and tablet self management apps for asthma. Cochrane Database Syst Rev 2013; 2013: Cd010013
• 302 de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V. et al. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev 2012; 12: Cd007459
• 303 Kohler B, Kellerer C, Schultz K. et al. An Internet-Based Asthma Self-Management Program Increases Knowledge About Asthma. Dtsch Arztebl Int 2020; 117: 64-71
• 304 Ainsworth B, Greenwell K, Stuart B. et al. Feasibility trial of a digital self-management intervention ‘My Breathing Matters’ to improve asthma-related quality of life for UK primary care patients with asthma. BMJ Open 2019; 9: e032465
• 305 Kassenärztliche Bundesvereinigung (KBV). DMP Asthma. Qualitätsziele und Qualitätsindikatoren. Letzter Zugriff am 25.05.2023: https://www.kbv.de/html/dmp.php
• 306 Siroux V, Pin I, Oryszczyn MP. et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J 2000; 15: 470-477
• 307 Ehrlich RI, Du Toit D, Jordaan E. et al. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking. Am J Respir Crit Care Med 1996; 154: 681-688
• 308 Bush A. Lung Development and Aging. Ann Am Thorac Soc 2016; 13 (Suppl. 05) S438-S446
• 309 Wang Z, May SM, Charoenlap S. et al. Effects of secondhand smoke exposure on asthma morbidity and health care utilization in children: a systematic review and meta-analysis. Ann Allergy Asthma Immunol 2015; 115: 396-401.e392
• 310 Jones LL, Hashim A, McKeever T. et al. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res 2011; 12: 5
• 311 Lazarus SC, Chinchilli VM, Rollings NJ. et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175: 783-790
• 312 Chaudhuri R, Livingston E, McMahon AD. et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133
• 313 Been JV, Nurmatov UB, Cox B. et al. Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet 2014; 383: 1549-1560
• 314 AWMF. S3-Leitlinie Rauchen und Tabakabhängigkeit: Screening, Diagnostik und Behandlung. 2021 Registernummer 076-006
• 315 Bals R, Boyd J, Esposito S. et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur Respir J 2019; 53: 1801151
• 316 Hajek P, Phillips-Waller A, Przulj D. et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med 2019; 380: 629-637
• 317 Santino TA, Chaves GS, Freitas DA. et al. Breathing exercises for adults with asthma. Cochrane Database Syst Rev 2020; 3: Cd001277
• 318 Balkissoon R, Kenn K. Asthma: vocal cord dysfunction (VCD) and other dysfunctional breathing disorders. Semin Respir Crit Care Med 2012; 33: 595-605
• 319 Ritz T, Rosenfield D, Steele AM. et al. Controlling asthma by training of Capnometry-Assisted Hypoventilation (CATCH) vs slow breathing: a randomized controlled trial. Chest 2014; 146: 1237-1247
• 320 Barker NJ, Jones M, O'Connell NE. et al. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in children. Cochrane Database Syst Rev 2013; Cd010376
• 321 Bruton A, Lee A, Yardley L. et al. Physiotherapy breathing retraining for asthma: a randomised controlled trial. Lancet Respir Med 2018; 6: 19-28
• 322 Wilson JJ, Theis SM, Wilson EM. Evaluation and management of vocal cord dysfunction in the athlete. Curr Sports Med Rep 2009; 8: 65-70
• 323 Barker NJ, Elphick H, Everard ML. The impact of a dedicated physiotherapist clinic for children with dysfunctional breathing. ERJ Open Res 2016; 2
• 324 Sandnes A, Andersen T, Clemm HH. et al. Exercise-induced laryngeal obstruction in athletes treated with inspiratory muscle training. BMJ Open Sport Exerc Med 2019; 5: e000436
• 325 Weise S, Kardos P, Pfeiffer-Kascha D. et al. Empfehlungen zur Atemphysiotherapie. 3. erw. Aufl. Oberhaching: Dustri-Verlag Dr. Karl Feistle; 2019. ISBN: 978-3-87185-545-0
• 326 Lehrer PM, Vaschillo E, Vaschillo B. et al. Biofeedback treatment for asthma. Chest 2004; 126: 352-361
• 327 Thomas M, McKinley RK, Mellor S. et al. Breathing exercises for asthma: a randomised controlled trial. Thorax 2009; 64: 55-61
• 328 Lingner H, Ernst S, Groβhennig A. et al. Asthma control and health-related quality of life one year after inpatient pulmonary rehabilitation: the ProKAR Study. J Asthma 2015; 52: 614-621
• 329 Spruit MA, Singh SJ, Garvey C. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-64
• 330 Ries AL, Bauldoff GS, Carlin BW. et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007; 131: 4s-42s
• 331 Wolff B, Cieza A, Parentin A. et al. Identifying the concepts contained in outcome measures of clinical trials on four internal disorders using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med 2004; 37-42
• 332 Szczepanski R, Jaeschke R, Spindler T. et al. Preschoolersʼ and parentsʼ asthma education trial (P2AET) – a randomized controlled study. Eur J Pediatr 2010; 169: 1051-1060
• 333 Warschburger P, Busch S, Bauer CP. et al. Health-related quality of life in children and adolescents with asthma: results from the ESTAR Study. J Asthma 2004; 41: 463-470
• 334 Schneeberger T, Jarosch I, Moll J. et al. Increased asthma control after a 3-week inpatient pulmonary rehabilitation program. Respir Med 2020; 165: 105930
• 335 Schultz K, Wittmann M, Wagner R. et al. In-Patient Pulmonary Rehabilitation to Improve Asthma Control – A Randomized Controlled Study (EPRA, Effectiveness of Pulmonary Rehabilitation for Patients with Asthma). Dtsch Arztebl Int 2021; 118: 23-30
• 336 Carson KV, Chandratilleke MG, Picot J. et al. Physical training for asthma. Cochrane Database Syst Rev 2013; Cd001116
• 337 Mendes FA, Gonçalves RC, Nunes MP. et al. Effects of aerobic training on psychosocial morbidity and symptoms in patients with asthma: a randomized clinical trial. Chest 2010; 138: 331-337
• 338 Turner S, Eastwood P, Cook A. et al. Improvements in symptoms and quality of life following exercise training in older adults with moderate/severe persistent asthma. Respiration 2011; 81: 302-310
• 339 Dogra S, Kuk JL, Baker J. et al. Exercise is associated with improved asthma control in adults. Eur Respir J 2011; 37: 318-323
• 340 Beggs S, Foong YC, Le HC. et al. Swimming training for asthma in children and adolescents aged 18 years and under. Cochrane Database Syst Rev 2013; Cd009607
• 341 Mickleborough TD, Lindley MR, Turner LA. Comparative effects of a high-intensity interval warm-up and salbutamol on the bronchoconstrictor response to exercise in asthmatic athletes. Int J Sports Med 2007; 28: 456-462
• 342 Slader CA, Reddel HK, Jenkins CR. et al. Complementary and alternative medicine use in asthma: who is using what?. Respirology 2006; 11: 373-387
• 343 Blackhall K, Appleton S, Cates CJ. Ionisers for chronic asthma. Cochrane Database Syst Rev 2012; 2012: Cd002986
• 344 Yang ZY, Zhong HB, Mao C. et al. Yoga for asthma. Cochrane Database Syst Rev 2016; 4: Cd010346
• 345 Yorke J, Fleming S, Shuldham C. et al. Nonpharmacological interventions aimed at modifying health and behavioural outcomes for adults with asthma: a critical review. Clin Exp Allergy 2015; 45: 1750-1764
• 346 Ernst E. Homeopathy: what does the “best” evidence tell us?. Med J Aust 2010; 192: 458-460
• 347 Li H, Chen H, Morgan L. et al. A narrative review of clinical studies of herbal treatment of difficult to manage asthma. Complement Ther Clin Pract 2021; 44: 101433
• 348 Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60: 740-746
• 349 Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013; 2013: Cd000052
• 350 Kew KM, Kirtchuk L, Michell CI. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database Syst Rev 2014; Cd010909
• 351 Camargo Jr CA, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003; 2003: Cd001115
• 352 Craven D, Kercsmar CM, Myers TR. et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. J Pediatr 2001; 138: 51-58
• 353 Vézina K, Chauhan BF, Ducharme FM. Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. Cochrane Database Syst Rev 2014; Cd010283
• 354 Travers AH, Milan SJ, Jones AP. et al. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev 2012; 12: Cd010179
• 355 Normansell R, Kew KM, Mansour G. Different oral corticosteroid regimens for acute asthma. Cochrane Database Syst Rev 2016; 2016: Cd011801
• 356 Bhogal SK, McGillivray D, Bourbeau J. et al. Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation. Ann Emerg Med 2012; 60: 84-91.e83
• 357 Ream RS, Loftis LL, Albers GM. et al. Efficacy of IV theophylline in children with severe status asthmaticus. Chest 2001; 119: 1480-1488
• 358 Wheeler DS, Jacobs BR, Kenreigh CA. et al. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. Pediatr Crit Care Med 2005; 6: 142-147
• 359 Travers AH, Jones AP, Camargo Jr CA. et al. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database Syst Rev 2012; 12: Cd010256
• 360 Andrews T, McGintee E, Mittal MK. et al. High-dose continuous nebulized levalbuterol for pediatric status asthmaticus: a randomized trial. J Pediatr 2009; 155: 205-210.e201
• 361 Griffiths B, Kew KM. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. Cochrane Database Syst Rev 2016; 4: Cd011050
• 362 Nievas IF, Anand KJ. Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit. J Pediatr Pharmacol Ther 2013; 18: 88-104
• 363 Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. J Emerg Med 2009; 37: S23-S34
• 364 Good Jr JT. Kolakowski CA, Groshong SD et al. Refractory asthma: importance of bronchoscopy to identify phenotypes and direct therapy. Chest 2012; 141: 599-606
• 365 Soroksky A, Klinowski E, Ilgyev E. et al. Noninvasive positive pressure ventilation in acute asthmatic attack. Eur Respir Rev 2010; 19: 39-45
• 366 Westhoff M, Schönhofer B, Neumann P. et al. [Noninvasive Mechanical Ventilation in Acute Respiratory Failure]. Pneumologie 2015; 69: 719-756
• 367 Fichtner F, Moerer O, Laudi S. et al. Mechanical Ventilation and Extracorporeal Membrane Oxygena tion in Acute Respiratory Insufficiency. Dtsch Arztebl Int 2018; 115: 840-847
• 368 Althoff MD, Holguin F, Yang F. et al. Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations. Am J Respir Crit Care Med 2020; 202: 1520-1530
• 369 Basnet S, Mander G, Andoh J. et al. Safety, efficacy, and tolerability of early initiation of noninvasive positive pressure ventilation in pediatric patients admitted with status asthmaticus: a pilot study. Pediatr Crit Care Med 2012; 13: 393-398
• 370 Mayordomo-Colunga J, Medina A, Rey C. et al. Non-invasive ventilation in pediatric status asthmaticus: a prospective observational study. Pediatr Pulmonol 2011; 46: 949-955
• 371 Lewis SR, Baker PE, Parker R. et al. High-flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database Syst Rev 2021; 3: Cd010172
• 372 D'Cruz RF, Hart N, Kaltsakas G. High-flow therapy: physiological effects and clinical applications. Breathe (Sheff) 2020; 16: 200224
• 373 Raeisi S, Fakharian A, Ghorbani F. et al. Value and Safety of High Flow Oxygenation in the Treatment of Inpatient Asthma: A Randomized, Double-blind, Pilot Study. Iran J Allergy Asthma Immunol 2019; 18: 615-623
• 374 Geng W, Batu W, You S. et al. High-Flow Nasal Cannula: A Promising Oxygen Therapy for Patients with Severe Bronchial Asthma Complicated with Respiratory Failure. Can Respir J 2020; 2020: 2301712
• 375 Ruangsomboon O, Limsuwat C, Praphruetkit N. et al. Nasal High-flow Oxygen Versus Conventional Oxygen Therapy for Acute Severe Asthma Patients: A Pilot Randomized Controlled Trial. Acad Emerg Med 2021; 28: 530-541
• 376 Butland BK, Ghosh R, Strachan DP. et al. Job choice and the influence of prior asthma and hay fever. Occup Environ Med 2011; 68: 494-501
• 377 Radon K, Riu E, Dressel H. et al. Adolescentsʼ jobs and the course of dermatitis symptoms throughout puberty. Scand J Work Environ Health 2006; 32: 132-137
• 378 Wei J, Gerlich J, Vogelberg C. et al. Do young adults with atopic dermatitis avoid harmful workplace exposure at their first job? A prospective cohort study. Int Arch Occup Environ Health 2016; 89: 397-406
• 379 Dumas O, Smit LA, Pin I. et al. Do young adults with childhood asthma avoid occupational exposures at first hire?. Eur Respir J 2011; 37: 1043-1049
• 380 Radon K, Nowak D, Vogelberg C. et al. Career Advice for Young Allergy Patients. Dtsch Arztebl Int 2016; 113: 519-524
• 381 Moscato G, Pala G, Boillat MA. et al. EAACI position paper: prevention of work-related respiratory allergies among pre-apprentices or apprentices and young workers. Allergy 2011; 66: 1164-1173
• 382 De Zotti R, Bovenzi M. Prospective study of work related respiratory symptoms in trainee bakers. Occup Environ Med 2000; 57: 58-61
• 383 Quirce S, Diaz-Perales A. Diagnosis and management of grain-induced asthma. Allergy Asthma Immunol Res 2013; 5: 348-356
• 384 Blanc PD, Annesi-Maesano I, Balmes JR. et al. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. Am J Respir Crit Care Med 2019; 199: 1312-1334
• 385 Mapp CE, Boschetto P, Maestrelli P. et al. Occupational asthma. Am J Respir Crit Care Med 2005; 172: 280-305
• 386 Kogevinas M, Zock JP, Jarvis D. et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007; 370: 336-341
• 387 Burge PS, Moore VC, Robertson AS. Sensitization and irritant-induced occupational asthma with latency are clinically indistinguishable. Occup Med (Lond) 2012; 62: 129-133
• 388 Nowak D. Chemosensory irritation and the lung. Int Arch Occup Environ Health 2002; 75: 326-331
• 389 Le Moual N, Siroux V, Pin I. et al. Asthma severity and exposure to occupational asthmogens. Am J Respir Crit Care Med 2005; 172: 440-445
• 390 Baur X. A compendium of causative agents of occupational asthma. J Occup Med Toxicol 2013; 8: 15
• 391 Wilken D, Baur X, Barbinova L. et al. What are the benefits of medical screening and surveillance?. Eur Respir Rev 2012; 21: 105-111
• 392 Preisser AM. Verbleib im Beruf mit Atemwegserkrankung – Lösungsansätze für die Individualprävention. Arbeitsmed Sozialmed Umweltmed 2021; 56: 194-195
• 393 Ochmann U, Kotschy-Lang N, Raab W. et al. Long-term efficacy of pulmonary rehabilitation in patients with occupational respiratory diseases. Respiration 2012; 84: 396-405
• 394 Reichenhaller Empfehlung. 2023
• 395 Vandenplas O, Ghezzo H, Munoz X. et al. What are the questionnaire items most useful in identifying subjects with occupational asthma?. Eur Respir J 2005; 26: 1056-1063
• 396 Lemiere C, NGuyen S, Sava F. et al. Occupational asthma phenotypes identified by increased fractional exhaled nitric oxide after exposure to causal agents. J Allergy Clin Immunol 2014; 134: 1063-1067
• 397 Engel J, van Kampen V, Lotz A. et al. An increase of fractional exhaled nitric oxide after specific inhalation challenge is highly predictive of occupational asthma. Int Arch Occup Environ Health 2018; 91: 799-809
• 398 Engel J, van Kampen V, Gering V. et al. Non-invasive tools beyond lung function before and after specific inhalation challenges for diagnosing occupational asthma. Int Arch Occup Environ Health 2019; 92: 1067-1076
• 399 Preisser AM, Koschel D, Merget R. et al. Workplace-related inhalation test – Specific inhalation challenge: S2k Guideline of the German Society for Occupational and Environmental Medicine e. V. (DGAUM), the German Society for Pneumology and Respiratory Medicine e. V. (DGP) and the German Society for Allergology and Clinical Immunology e. V. (DGAKI). Allergol Select 2021; 5: 315-334
• 400 Vandenplas O, D'Alpaos V, Heymans J. et al. Sputum eosinophilia: an early marker of bronchial response to occupational agents. Allergy 2009; 64: 754-761
• 401 Malo JL, Cardinal S, Ghezzo H. et al. Association of bronchial reactivity to occupational agents with methacholine reactivity, sputum cells and immunoglobulin E-mediated reactivity. Clin Exp Allergy 2011; 41: 497-504
• 402 Vandenplas O, Dressel H, Nowak D. et al. What is the optimal management option for occupational asthma?. Eur Respir Rev 2012; 21: 97-104
• 403 Vandenplas O, Dressel H, Wilken D. et al. Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J 2011; 38: 804-811
• 404 Henneberger PK, Patel JR, de Groene GJ. et al. Workplace interventions for treatment of occupational asthma. Cochrane Database Syst Rev 2019; 10: Cd006308
• 405 Henneberger PK, Patel JR, de Groene GJ. et al. The effectiveness of removal from exposure and reduction of exposure for managing occupational asthma: Summary of an updated Cochrane systematic review. Am J Ind Med 2021; 64: 165-169
• 406 Heederik D, Henneberger PK, Redlich CA. Primary prevention: exposure reduction, skin exposure and respiratory protection. Eur Respir Rev 2012; 21: 112-124
• 407 Baur X, Sigsgaard T, Aasen TB. et al. Guidelines for the management of work-related asthma. Eur Respir J 2012; 39: 529-545
• 408 Schatz M, Dombrowski MP. Clinical practice. Asthma in pregnancy. N Engl J Med 2009; 360: 1862-1869
• 409 Gluck JC, Gluck PA. The effect of pregnancy on the course of asthma. Immunol Allergy Clin North Am 2006; 26: 63-80
• 410 Murphy VE, Gibson PG, Smith R. et al. Asthma during pregnancy: mechanisms and treatment implications. Eur Respir J 2005; 25: 731-750
• 411 Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006; 61: 169-176
• 412 Cydulka RK, Emerman CL, Schreiber D. et al. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999; 160: 887-892
• 413 Murphy VE, Powell H, Wark PAB. et al. A prospective study of respiratory viral infection in pregnant women with and without asthma. Chest 2013; 144: 420-427
• 414 Mendola P, Laughon SK, Männistö TI. et al. Obstetric complications among US women with asthma. Am J Obstet Gynecol 2013; 208: 127.e121-128
• 415 Murphy VE, Gibson PG. Asthma in pregnancy. Clin Chest Med 2011; 32: 93-110
• 416 Salihu HM, Wilson RE. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev 2007; 83: 713-720
• 417 Hodyl NA, Stark MJ, Scheil W. et al. Perinatal outcomes following maternal asthma and cigarette smoking during pregnancy. Eur Respir J 2014; 43: 704-716
• 418 Lumley J, Chamberlain C, Dowswell T. et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009; Cd001055
• 419 Lim AS, Stewart K, Abramson MJ. et al. Multidisciplinary Approach to Management of Maternal Asthma (MAMMA): a randomized controlled trial. Chest 2014; 145: 1046-1054
• 420 Lim A, Stewart K, König K. et al. Systematic review of the safety of regular preventive asthma medications during pregnancy. Ann Pharmacother 2011; 45: 931-945
• 421 Vogt H, Lindström K, Bråbäck L. et al. Preterm birth and inhaled corticosteroid use in 6- to 19-year-olds: a Swedish national cohort study. Pediatrics 2011; 127: 1052-1059
• 422 Schatz M, Leibman C. Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol 2005; 95: 234-238
• 423 Ramos CL, Namazy J. Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation. Immunol Allergy Clin North Am 2023; 43: 187-197
• 424 Shakuntulla F, Chiarella SE. Safety of Biologics for Atopic Diseases During Pregnancy. J Allergy Clin Immunol Pract 2022; 10: 3149-3155
• 425 Namazy J, Cabana MD, Scheuerle AE. et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. J Allergy Clin Immunol 2015; 135: 407-412
• 426 Namazy JA, Blais L, Andrews EB. et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol 2020; 145: 528-536.e521
• 427 Mylonas I. Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration. Arch Gynecol Obstet 2011; 283: 7-18
• 428 Gottlieb J, Capetian P, Hamsen U. et al. German S3 Guideline: Oxygen Therapy in the Acute Care of Adult Patients. Respiration 2022; 101: 214-252
• 429 Lommatzsch M, Brusselle GG, Levy ML. et al. A2BCD: a concise guide for asthma management. Lancet Respir Med 2023;
• 430 Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007; 56: 1654-1664
• 431 Tsai MC, Lin HL, Lin CC. et al. Increased risk of concurrent asthma among patients with gastroesophageal reflux disease: a nationwide population-based study. Eur J Gastroenterol Hepatol 2010; 22: 1169-1173
• 432 Chan WW, Chiou E, Obstein KL. et al. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. Arch Intern Med 2011; 171: 620-629
• 433 Holbrook JT, Wise RA, Gold BD. et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. Jama 2012; 307: 373-381
• 434 Mastronarde JG, Anthonisen NR, Castro M. et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360: 1487-1499
• 435 Zheng Z, Luo Y, Li J. et al. Randomised trials of proton pump inhibitors for gastro-oesophageal reflux disease in patients with asthma: an updated systematic review and meta-analysis. BMJ Open 2021; 11: e043860
• 436 Todd DC, Armstrong S, D'Silva L. et al. Effect of obesity on airway inflammation: a cross-sectional analysis of body mass index and sputum cell counts. Clin Exp Allergy 2007; 37: 1049-1054
• 437 Kim KM, Kim SS, Kwon JW. et al. Association between subcutaneous abdominal fat and airway hyperresponsiveness. Allergy Asthma Proc 2011; 32: 68-73
• 438 Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med 2018; 12: 755-767
• 439 Farah CS, Kermode JA, Downie SR. et al. Obesity is a determinant of asthma control independent of inflammation and lung mechanics. Chest 2011; 140: 659-666
• 440 Dixon AE, Holguin F. Diet and Metabolism in the Evolution of Asthma and Obesity. Clin Chest Med 2019; 40: 97-106
• 441 Farah CS, Boulet LP, Reddel HK. Obesity and asthma control in an urban population. J Allergy Clin Immunol 2010; 125: 769-770 author reply 770
• 442 Eneli IU, Skybo T, Camargo CA. et al. Weight loss and asthma: a systematic review. Thorax 2008; 63: 671-676
• 443 Thomsen SF, Ulrik CS, Kyvik KO. et al. Association between obesity and asthma in a twin cohort. Allergy 2007; 62: 1199-1204
• 444 Sood A. Sex differences: implications for the obesity-asthma association. Exerc Sport Sci Rev 2011; 39: 48-56
• 445 Musaad SM, Patterson T, Ericksen M. et al. Comparison of anthropometric measures of obesity in childhood allergic asthma: central obesity is most relevant. J Allergy Clin Immunol 2009; 123: 1321-1327.e1312
• 446 Forno E, Lescher R, Strunk R. et al. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol 2011; 127: 741-749
• 447 Cardet JC, Ash S, Kusa T. et al. Insulin resistance modifies the association between obesity and current asthma in adults. Eur Respir J 2016; 48: 403-410
• 448 van Huisstede A, Rudolphus A, Castro Cabezas M. et al. Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma. Thorax 2015; 70: 659-667
• 449 Julien JY, Martin JG, Ernst P. et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 2009; 124: 371-376
• 450 Prasad B, Nyenhuis SM, Imayama I. et al. Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?. Am J Respir Crit Care Med 2020; 201: 1345-1357
• 451 Mayer G, Arzt M, Braumann B. et al. German S3 Guideline Nonrestorative Sleep/Sleep Disorders, chapter “Sleep-Related Breathing Disorders in Adults,” short version: German Sleep Society (Deutsche Gesellschaft für Schlafforschung und Schlafmedizin, DGSM). Somnologie (Berl) 2017; 21: 290-301
• 452 Pfeffer PE, Hawrylowicz CM. Vitamin D in Asthma: Mechanisms of Action and Considerations for Clinical Trials. Chest 2018; 153: 1229-1239
• 453 Forno E, Bacharier LB, Phipatanakul W. et al. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial. Jama 2020; 324: 752-760
• 454 Hardin M, Silverman EK, Barr RG. et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011; 12: 127
• 455 Bonten TN, Kasteleyn MJ, de Mutsert R. et al. Defining asthma-COPD overlap syndrome: a population-based study. Eur Respir J 2017; 49: 1602008
• 456 Adrish M, Anand MP, Hanania NA. Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am 2022; 42: 645-655
• 457 Pleasants RA, Ohar JA, Croft JB. et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. Copd 2014; 11: 256-266
• 458 Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. Copd 2011; 8: 400-407
• 459 Brightling CE, McKenna S, Hargadon B. et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005; 60: 193-198
• 460 Singh D, Agusti A, Martinez FJ. et al. Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. Am J Respir Crit Care Med 2022; 206: 17-24
• 461 Annangi S, Nutalapati S, Sturgill J. et al. Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease. Thorax 2022; 77: 351-356
• 462 Fokkens W, Reitsma S. Unified Airway Disease: A Contemporary Review and Introduction. Otolaryngol Clin North Am 2023; 56: 1-10
• 463 Brożek JL, Bousquet J, Agache I. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017; 140: 950-958
• 464 Bachert C, Han JK, Wagenmann M. et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management. J Allergy Clin Immunol 2021; 147: 29-36
• 465 Marple BF. Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace. Am J Rhinol Allergy 2010; 24: 249-254
• 466 Huovinen E, Kaprio J, Laitinen LA. et al. Incidence and prevalence of asthma among adult Finnish men and women of the Finnish Twin Cohort from 1975 to 1990, and their relation to hay fever and chronic bronchitis. Chest 1999; 115: 928-936
• 467 Guerra S, Sherrill DL, Martinez FD. et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109: 419-425
• 468 Pinart M, Benet M, Annesi-Maesano I. et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2014; 2: 131-140
• 469 Ciprandi G, Cirillo I, Tosca MA. et al. Bronchial hyperreactivity and spirometric impairment in patients with seasonal allergic rhinitis. Respir Med 2004; 98: 826-831
• 470 Ciprandi G, Cirillo I, Tosca MA. et al. Bronchial hyperreactivity and spirometric impairment in patients with perennial allergic rhinitis. Int Arch Allergy Immunol 2004; 133: 14-18
• 471 Braunstahl GJ, Kleinjan A, Overbeek SE. et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161: 2051-2057
• 472 Braunstahl GJ, Overbeek SE, Kleinjan A. et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107: 469-476
• 473 Gaga M, Lambrou P, Papageorgiou N. et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000; 30: 663-669
• 474 Crystal-Peters J, Neslusan C, Crown WH. et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109: 57-62
• 475 Corren J, Manning BE, Thompson SF. et al. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004; 113: 415-419
• 476 Gevaert P, Omachi TA, Corren J. et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol 2020; 146: 595-605
• 477 Rhodes HL, Sporik R, Thomas P. et al. Early life risk factors for adult asthma: a birth cohort study of subjects at risk. J Allergy Clin Immunol 2001; 108: 720-725
• 478 Fiocchi A, Terracciano L, Bouygue GR. et al. Incremental prognostic factors associated with cowʼs milk allergy outcomes in infant and child referrals: the Milan Cowʼs Milk Allergy Cohort study. Ann Allergy Asthma Immunol 2008; 101: 166-173
• 479 Friedlander JL, Sheehan WJ, Baxi SN. et al. Food allergy and increased asthma morbidity in a School-based Inner-City Asthma Study. J Allergy Clin Immunol Pract 2013; 1: 479-484
• 480 Wang J, Visness CM, Sampson HA. Food allergen sensitization in inner-city children with asthma. J Allergy Clin Immunol 2005; 115: 1076-1080
• 481 Roberts G, Patel N, Levi-Schaffer F. et al. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol 2003; 112: 168-174
• 482 Berns SH, Halm EA, Sampson HA. et al. Food allergy as a risk factor for asthma morbidity in adults. J Asthma 2007; 44: 377-381
• 483 Amat F, Soria A, Tallon P. et al. New insights into the phenotypes of atopic dermatitis linked with allergies and asthma in children: An overview. Clin Exp Allergy 2018; 48: 919-934
• 484 Paller AS, Spergel JM, Mina-Osorio P. et al. The atopic march and atopic multimorbidity: Many trajectories, many pathways. J Allergy Clin Immunol 2019; 143: 46-55
• 485 Lee JK, Han D. Atopic dermatitis is an important comorbidity in severe asthma. Ann Allergy Asthma Immunol 2018; 120: 661-662
• 486 Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 2008; 70: 102-116
• 487 Wamboldt MZ, Hewitt JK, Schmitz S. et al. Familial association between allergic disorders and depression in adult Finnish twins. Am J Med Genet 2000; 96: 146-153
• 488 Ressler KJ, Mercer KB, Bradley B. et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011; 470: 492-497
• 489 Rosenberg SL, Miller GE, Brehm JM. et al. Stress and asthma: novel insights on genetic, epigenetic, and immunologic mechanisms. J Allergy Clin Immunol 2014; 134: 1009-1015
• 490 Suglia SF, Duarte CS, Sandel MT. et al. Social and environmental stressors in the home and childhood asthma. J Epidemiol Community Health 2010; 64: 636-642
• 491 Wright RJ. Stress and atopic disorders. J Allergy Clin Immunol 2005; 116: 1301-1306
• 492 Rod NH, Kristensen TS, Lange P. et al. Perceived stress and risk of adult-onset asthma and other atopic disorders: a longitudinal cohort study. Allergy 2012; 67: 1408-1414
• 493 Kullowatz A, Rosenfield D, Dahme B. et al. Stress effects on lung function in asthma are mediated by changes in airway inflammation. Psychosom Med 2008; 70: 468-475
• 494 Ritz T, Ayala ES, Trueba AF. et al. Acute stress-induced increases in exhaled nitric oxide in asthma and their association with endogenous cortisol. Am J Respir Crit Care Med 2011; 183: 26-30
• 495 Chen E, Strunk RC, Bacharier LB. et al. Socioeconomic status associated with exhaled nitric oxide responses to acute stress in children with asthma. Brain Behav Immun 2010; 24: 444-450
• 496 Bockelbrink A, Heinrich J, Schäfer I. et al. Atopic eczema in children: another harmful sequel of divorce. Allergy 2006; 61: 1397-1402
• 497 Lietzén R, Virtanen P, Kivimäki M. et al. Stressful life events and the onset of asthma. Eur Respir J 2011; 37: 1360-1365
• 498 Spitzer C, Koch B, Grabe HJ. et al. Association of airflow limitation with trauma exposure and post-traumatic stress disorder. Eur Respir J 2011; 37: 1068-1075
• 499 Scott KM, Von Korff M, Alonso J. et al. Childhood adversity, early-onset depressive/anxiety disorders, and adult-onset asthma. Psychosom Med 2008; 70: 1035-1043
• 500 Brackbill RM, Hadler JL, DiGrande L. et al. Asthma and posttraumatic stress symptoms 5 to 6 years following exposure to the World Trade Center terrorist attack. Jama 2009; 302: 502-516
• 501 Wright RJ, Fay ME, Suglia SF. et al. War-related stressors are associated with asthma risk among older Kuwaitis following the 1990 Iraqi invasion and occupation. J Epidemiol Community Health 2010; 64: 630-635
• 502 Goodwin RD, Stein MB. Association between childhood trauma and physical disorders among adults in the United States. Psychol Med 2004; 34: 509-520
• 503 Douwes J, Brooks C, Pearce N. Stress and asthma: Hippocrates revisited. J Epidemiol Community Health 2010; 64: 561-562
• 504 Andersson NW, Hansen MV, Larsen AD. et al. Prenatal maternal stress and atopic diseases in the child: a systematic review of observational human studies. Allergy 2016; 71: 15-26
• 505 Cookson H, Granell R, Joinson C. et al. Mothersʼ anxiety during pregnancy is associated with asthma in their children. J Allergy Clin Immunol 2009; 123: 847-853.e811
• 506 de Marco R, Pesce G, Girardi P. et al. Foetal exposure to maternal stressful events increases the risk of having asthma and atopic diseases in childhood. Pediatr Allergy Immunol 2012; 23: 724-729
• 507 Grizenko N, Osmanlliu E, Fortier M. et al. Increased Risk of Asthma in Children with ADHD: Role of Prematurity and Maternal Stress during Pregnancy. J Can Acad Child Adolesc Psychiatry 2015; 24: 109-115
• 508 Guxens M, Sonnenschein-van der Voort AM, Tiemeier H. et al. Parental psychological distress during pregnancy and wheezing in preschool children: the Generation R Study. J Allergy Clin Immunol 2014; 133: 59-67.e51-12
• 509 Lange NE, Bunyavanich S, Silberg JL. et al. Parental psychosocial stress and asthma morbidity in Puerto Rican twins. J Allergy Clin Immunol 2011; 127: 734-740.e731-737
• 510 Choi HG, Kim JH, Park JY. et al. Association Between Asthma and Depression: A National Cohort Study. J Allergy Clin Immunol Pract 2019; 7: 1239-1245.e1231
• 511 Meister J. Biopsychosoziale Entwicklung bei Kindern und Jugendlichen mit Allergien. Verschiedene Lebensphasen und ihre Bewältigungsanforderungen. Pädiatrische Allergologie 2021; 24: 6-14
• 512 Miyazaki C, Koyama M, Ota E. et al. Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis. BMC Psychiatry 2017; 17: 120
• 513 Kittel-Schneider S, Arteaga-Henriquez G, Vasquez AA. et al. Non-mental diseases associated with ADHD across the lifespan: Fidgety Philipp and Pippi Longstocking at risk of multimorbidity?. Neurosci Biobehav Rev 2022; 132: 1157-1180
• 514 Gupta MA, Gupta AK, Schork NJ. et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994; 56: 36-40
• 515 Chen E, Hermann C, Rodgers D. et al. Symptom perception in childhood asthma: the role of anxiety and asthma severity. Health Psychol 2006; 25: 389-395
• 516 Cluley S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med 2001; 95: 37-39
• 517 McQuaid EL, Kopel SJ, Nassau JH. Behavioral adjustment in children with asthma: a meta-analysis. J Dev Behav Pediatr 2001; 22: 430-439
• 518 Vila G, Hayder R, Bertrand C. et al. Psychopathology and quality of life for adolescents with asthma and their parents. Psychosomatics 2003; 44: 319-328
• 519 Tzeng NS, Chang HA, Chung CH. et al. Increased Risk of Psychiatric Disorders in Allergic Diseases: A Nationwide, Population-Based, Cohort Study. Front Psychiatry 2018; 9: 133
• 520 Cortese S, Sun S, Zhang J. et al. Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study. Lancet Psychiatry 2018; 5: 717-726
• 521 Schans JV, Çiçek R, de Vries TW. et al. Association of atopic diseases and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses. Neurosci Biobehav Rev 2017; 74: 139-148
• 522 Chen MH, Su TP, Chen YS. et al. Higher risk of mood disorders among adolescents with ADHD and asthma: a nationwide prospective study. J Affect Disord 2014; 156: 232-235
• 523 Chan A, De Simoni A, Wileman V. et al. Digital interventions to improve adherence to maintenance medication in asthma. Cochrane Database Syst Rev 2022; 6: Cd013030
• 524 Himes BE, Leszinsky L, Walsh R. et al. Mobile Health and Inhaler-Based Monitoring Devices for Asthma Management. J Allergy Clin Immunol Pract 2019; 7: 2535-2543
• 525 Braun M, Schmidt O, Schultz T. et al. [Experiences with digital care of patients with chronic and acute lung diseases during the SARS-CoV-2 pandemic]. Internist (Berl) 2022; 63: 255-265
• 526 Burgess SW, Sly PD, Devadason SG. Providing feedback on adherence increases use of preventive medication by asthmatic children. J Asthma 2010; 47: 198-201
• 527 Ireland AM, Wiklund I, Hsieh R. et al. An electronic diary is shown to be more reliable than a paper diary: results from a randomized crossover study in patients with persistent asthma. J Asthma 2012; 49: 952-960
• 528 Kupczyk M, Haque S, Sterk PJ. et al. Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study. Thorax 2013; 68: 611-618
• 529 Kupczyk M, Hofman A, Kołtowski Ł. et al. Home self-monitoring in patients with asthma using a mobile spirometry system. J Asthma 2021; 58: 505-511
• 530 Foster JM, Usherwood T, Smith L. et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. J Allergy Clin Immunol 2014; 134: 1260-1268.e1263
• 531 Chan AH, Stewart AW, Harrison J. et al. The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: a randomised controlled trial. Lancet Respir Med 2015; 3: 210-219
• 532 Barrett MA, Humblet O, Marcus JE. et al. Effect of a mobile health, sensor-driven asthma management platform on asthma control. Ann Allergy Asthma Immunol 2017; 119: 415-421.e411
• 533 Kosse RC, Bouvy ML, de Vries TW. et al. Effect of a mHealth intervention on adherence in adolescents with asthma: A randomized controlled trial. Respir Med 2019; 149: 45-51
• 534 Mosnaim GS, Stempel DA, Gonzalez C. et al. The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial. J Allergy Clin Immunol Pract 2021; 9: 1586-1594